Potent cytotoxic effects of Calomeria amaranthoides on ovarian cancers
Open Access
- 14 March 2011
- journal article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 30 (1) , 29
Abstract
Ovarian cancer remains the leading cause of death from gynaecological malignancy. More than 60% of the patients are presenting the disease in stage III or IV. In spite of combination of chemotherapy and surgery the prognosis stays poor for therapy regimen.Keywords
This publication has 14 references indexed in Scilit:
- Anti-Cancer Potential of Sesquiterpene Lactones: Bioactivity and Molecular MechanismsCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- A reassessment of the genus Haeckeria (Asteraceae: Gnaphalieae), with definition of new species in CassiniaAustralian Systematic Botany, 2004
- Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel versus cisplatin and paclitaxel (GOG158) and an update on GOG0182-ICON5International Journal of Gynecological Cancer, 2003
- Optimizing primary chemotherapy in ovarian cancerHematology/Oncology Clinics of North America, 2003
- INK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescenceThe EMBO Journal, 2002
- ETHNOPHARMACOLOGY OF MEXICAN ASTERACEAE (COMPOSITAE)Annual Review of Pharmacology and Toxicology, 1998
- An in vitro study of ovarian atypical proliferating (borderline) serous tumorsInternational Journal of Gynecological Cancer, 1992
- Eremophilane derivatives and other constituents from Haeckeria species and further Australian inuleaePhytochemistry, 1991
- Two further eremophilane derivatives from Tessaria absynthioidesPhytochemistry, 1977
- Toxic effect of alantolactone and dihydroalantolactone in in vitro cultures of leukocytesChemico-Biological Interactions, 1976